Shumei Kato

Shumei Kato

UNVERIFIED PROFILE

Are you Shumei Kato?   Register this Author

Register author
Shumei Kato

Shumei Kato

Publications by authors named "Shumei Kato"

Are you Shumei Kato?   Register this Author

51Publications

1068Reads

17Profile Views

Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics.

Mol Cancer Ther 2019 Oct 18;18(10):1852-1862. Epub 2019 Jul 18.

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-18-0965DOI Listing
October 2019

Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis.

Mol Cancer Ther 2019 06 23;18(6):1149-1157. Epub 2019 Apr 23.

Center for Personalized Cancer Therapy, Division of Blood and Marrow Transplantation, Division of Hematology/Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-18-1244DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548628PMC
June 2019

Temporal and spatial effects and survival outcomes associated with concordance between tissue and blood KRAS alterations in the pan-cancer setting.

Int J Cancer 2019 Jun 14. Epub 2019 Jun 14.

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego, Moores Cancer Center, La Jolla, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32510DOI Listing
June 2019

Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients.

Mol Cancer Ther 2019 02 6;18(2):448-458. Epub 2018 Dec 6.

Division of Hematology/Oncology, Department of Medicine, Center for Personalized Cancer Therapy, Moores Cancer Center, University of California, San Diego, San Diego, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-18-0535DOI Listing
February 2019

Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival.

JCO Precis Oncol 2019 25;3. Epub 2019 Jan 25.

Shumei Kato, Maria C. Schwaederlé, Paul T. Fanta, Ryosuke Okamura, Lawrence Leichman, and Scott M. Lippman, Razelle Kurzrock, University of California San Diego Moores Cancer Center, La Jolla; and Richard B. Lanman, Victoria M. Raymond, and AmirAli Talasaz, Guardant Health, Redwood City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.18.00158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484865PMC
January 2019

Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma.

Clin Cancer Res 2018 12 22;24(24):6248-6256. Epub 2018 Oct 22.

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-1128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384095PMC
December 2018

An avatar for precision cancer therapy.

Nat Biotechnol 2018 11;36(11):1053-1055

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/nbt.4293
Publisher Site
http://dx.doi.org/10.1038/nbt.4293DOI Listing
November 2018

JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: Implications for early diagnosis.

Cancer Biol Ther 2018 08;19(8):664-668

a Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine , University of California San Diego Moores Cancer Center , La Jolla , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384047.2018.1450120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067874PMC
August 2018

Analysis of Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies.

JCO Precis Oncol 2018 13;2018. Epub 2018 Jul 13.

University of California, San Diego, Moores Cancer Center, La Jolla.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106866PMC
http://dx.doi.org/10.1200/PO.17.00235DOI Listing
July 2018

Razelle Kurzrock and Shumei Kato on Immunotherapy and Hyperprogression of Disease.

Oncology (Williston Park) 2018 04;32(4):150-1, 163

View Article

Download full-text PDF

Source
April 2018

Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach.

Oncologist 2018 02 16;23(2):171-178. Epub 2017 Oct 16.

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, San Diego, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0199DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813742PMC
February 2018

Molecular Tumor Boards: Realizing Precision Oncology Therapy.

Clin Pharmacol Ther 2018 02 14;103(2):206-209. Epub 2017 Nov 14.

Center for Personalized Cancer Therapy and Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, Moores Cancer Center, La Jolla, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.920DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760337PMC
February 2018

Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers.

Cancer Discov 2017 12 11;7(12):1464-1479. Epub 2017 Sep 11.

Department of Pathology, Moores UCSD Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, California.

View Article

Download full-text PDF

Source
http://cancerdiscovery.aacrjournals.org/lookup/doi/10.1158/2
Publisher Site
http://dx.doi.org/10.1158/2159-8290.CD-17-0539DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718959PMC
December 2017

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers.

Mol Cancer Ther 2017 11 23;16(11):2598-2608. Epub 2017 Aug 23.

Division of Hematology/Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://mct.aacrjournals.org/lookup/doi/10.1158/1535-7163.MCT
Publisher Site
http://dx.doi.org/10.1158/1535-7163.MCT-17-0386DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670009PMC
November 2017

Genomics of Immunotherapy-Associated Hyperprogressors-Response.

Clin Cancer Res 2017 10;23(20):6376

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, San Diego, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1990DOI Listing
October 2017

Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate.

Clin Cancer Res 2017 Aug 28;23(15):4242-4250. Epub 2017 Mar 28.

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California, San Diego Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-3133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647162PMC
August 2017

Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary.

Cancer Res 2017 08 22;77(16):4238-4246. Epub 2017 Jun 22.

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-0628DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729906PMC
August 2017

Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients.

Clin Cancer Res 2017 04 28;23(8):1988-1997. Epub 2016 Sep 28.

Department of Medicine, Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California, San Diego, Moores Cancer Center, San Diego, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1679DOI Listing
April 2017

Genomic Landscape of Malignant Mesotheliomas.

Mol Cancer Ther 2016 10 9;15(10):2498-2507. Epub 2016 Aug 9.

Department of Medicine, Center for Personalized Cancer Therapy and Division of Hematology and Oncology, UC San Diego Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-16-0229DOI Listing
October 2016

The Conundrum of Genetic "Drivers" in Benign Conditions.

J Natl Cancer Inst 2016 08 7;108(8). Epub 2016 Apr 7.

Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston, TX (SK); Center for Personalized Cancer Therapy and Division of Hematology and Oncology, UC San Diego Moores Cancer Center, La Jolla, CA (SML, RK); Henri and Belinda Termeer Center for Targeted Therapies, Massachusetts General Hospital Cancer Center, Boston, MA (KTF).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017937PMC
August 2016

Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted Therapeutics.

Mol Cancer Ther 2016 07 11;15(7):1682-90. Epub 2016 May 11.

Center for Personalized Cancer Therapy, UC San Diego Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://mct.aacrjournals.org/lookup/doi/10.1158/1535-7163.MCT
Publisher Site
http://dx.doi.org/10.1158/1535-7163.MCT-16-0071DOI Listing
July 2016

Cell-free DNA as a novel marker in cancer therapy.

Biomark Med 2015 ;9(7):703-12

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, FC8.2018, Box 0455, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/bmm.15.38DOI Listing
April 2016

Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics.

Cell Cycle 2015 ;14(8):1252-9

a Center for Personalized Cancer Therapy and Division of Hematology and Oncology ; Department of Medicine; UC San Diego Moores Cancer Center ; La Jolla , CA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384101.2015.1014149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614867PMC
January 2016

A window-of-opportunity biomarker study of etodolac in resectable breast cancer.

Cancer Med 2015 Oct 15;4(10):1583-8. Epub 2015 Aug 15.

Department of Medicine, U.C. San Diego Moores Cancer Center, 3855 Health Sciences Dr., La Jolla, California, 92093.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.512DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618628PMC
October 2015

Genomic landscape of salivary gland tumors.

Oncotarget 2015 Sep;6(28):25631-45

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego, Moores Cancer Center, La Jolla, CA, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/4554
Publisher Site
http://dx.doi.org/10.18632/oncotarget.4554DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694855PMC
September 2015

Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patients.

Oncoscience 2015 8;2(7):646-58. Epub 2015 Jul 8.

Department of Phase I Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549362PMC
http://dx.doi.org/10.18632/oncoscience.176DOI Listing
September 2015

Challenges and perspective of drug repurposing strategies in early phase clinical trials.

Oncoscience 2015 30;2(6):576-80. Epub 2015 Jun 30.

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506360PMC
http://dx.doi.org/10.18632/oncoscience.173DOI Listing
August 2015

Identification of residual risk factors for the development of venous thromboembolism in medical inpatients receiving subcutaneous heparin therapy for prophylaxis.

Coron Artery Dis 2012 Jun;23(4):294-7

Department of Medicine, Beth Israel Medical Center, University Hospital and Manhattan Campus for the Albert Einstein College of Medicine, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCA.0b013e328352e510DOI Listing
June 2012

Heparin-induced thrombocytopenia: analysis of risk factors in medical inpatients.

Br J Haematol 2011 Aug 26;154(3):373-7. Epub 2011 May 26.

Beth Israel Medical Center, University Hospital and Manhattan Campus for Albert Einstein College of Medicine, New York, NY 10003, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2011.08746.xDOI Listing
August 2011

Relationship between proteinuria and venous thromboembolism.

J Thromb Thrombolysis 2010 Oct;30(3):281-5

Department of Medicine, Beth Israel Medical Center, University Hospital and Manhattan Campus for the Albert Einstein College of Medicine, First Avenue at 16th Street, New York, NY 10003, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s11239-010-0442
Web Search
http://link.springer.com/10.1007/s11239-010-0442-z
Publisher Site
http://dx.doi.org/10.1007/s11239-010-0442-zDOI Listing
October 2010